Dr Kent Hunter - National Cancer Institute, Bethesda, USA
Dr Kent Hunter, National Cancer Institute, Bethesda, USA, speaking at AACR 2009: Looking at the genetic determinants for breast cancer spread in order to predict which patients are likely to develop metastatic disease and tailor treatment accordingly. Investigating SIP A1, BRD4, RRP1B and TTC9C proteins.